NCT01231464View on ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

July 31, 2010

Conditions
Rhinitis, Allergic, PerennialAllergic Rhinitis
Interventions
DRUG

fluticasone furoate nasal spray

fluticasone furoate nasal spray 110ug, once daily

DRUG

placebo

placebo

Trial Locations (7)

100730

GSK Investigational Site, Beijing

200001

GSK Investigational Site, Shanghai

200031

GSK Investigational Site, Shanghai

210029

GSK Investigational Site, Nanjing

310003

GSK Investigational Site, Hangzhou

430022

GSK Investigational Site, Wuhan

610041

GSK Investigational Site, Chengdu

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01231464 - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis | Biotech Hunter | Biotech Hunter